Caring for the world, one person at a time, inspires and unites the people of Johnson & Johnson. We embrace innovation bringing ideas, products, and services to life to advance the health and well-being of people around the world. We believe in collaboration which has led to breakthrough after breakthrough, from medical miracles that have cha ...
nged lives, to consumer products that make every day a little better.
Our over 125,000 employees in 60 countries are united in a common mission: To help people everywhere live longer, healthier, happier lives.
DPDS (Discovery, Pharmaceutical Development & Supply) is the molecular invention engine for Johnson & Johnson, focused on where people are passionate about being the fastest at translating the best ideas into unique outstanding therapies for patients. Comprised of ~4,200 employees around the world, DPDS partners with other global functions to deliver sustained product innovation from target identification through end-of-product life across all therapeutic modalities, including Small Molecules, Proteins, RNA Therapy, Gene Therapy & Cell Therapy.
The Johnson & Johnson campus in Beerse, Antwerp (Belgium) has a unique ecosystem covering the complete drug development life cycle, with all capabilities from basic science to market access on one campus. The integrated environment of our campus gives our people the chance to experience many different aspects of drug development throughout their careers. It has a successful track record of over sixty years of drug discovery and development and is one of the most important innovation engines of the Johnson & Johnson group worldwide.
You will be responsible for conducting research directed to developing creative solutions to synthetic organic chemistry problems across a portfolio of projects.
In the Discovery Process Research (DPR) team, we focus on developing new synthetic organic transformations. The DPR team operates across a portfolio of projects at the interface of the discovery and development space, from lead identification through the selection of drug candidates. The group facilitates medicinal chemistry research by finding solutions to synthetic bottlenecks, enabling access to novel chemical space, and translating chemistry innovations to the development of efficient routes for the synthesis of small molecule drug candidates advancing into development.
The API Development chemistry team (DC) team generates creative and innovative ways towards new synthetic routes and solutions that enable large scale manufacturing of target Active Pharmaceutical Ingredients. Process chemists and engineers team up with analysts, crystallization, and safety experts to design the best manufacturing process. These teams work closely together with the pilot plants and bridge with commercial production. New chemical processes are developed meeting stringent requirements concerning safety, environment, technology, economy, and quality. As a result of these endeavours, drug candidates are accelerated through the development pipeline by enabling sufficient
supplies of active ingredient in support of clinical trials, registration and finally commercialization.
In both the DPR as well as the DC teams, internship positions are available with the focus on synthetic organic chemistry. This vacancy text serves as general description for several possible internship positions.
Mentored by an industry expert, you will contribute to the development of synthetic routes towards organic molecules in the context of a drug discovery or development project. The ultimate goal is to contribute to delivering synthetic methods that enable medicinal chemistry activities in finding novel drug candidate molecules (=diversity-oriented approaches), or provide methods that enable a more efficient, scalable, green and sustainable production of selected compounds (=target-oriented approaches). In both contexts, you will have the chance to contribute to the improvement of the lives of patients.
